Concomitant levosimendan and esmolol infusion in ischaemic cardiogenic shock

British Journal of Anaesthesia

Volumn 104, Issue 3, 2010, Pages 388-389

  Guarracino, F ^a   Landoni, G ^a   Baldassarri, R ^a   Nobile, L ^a   Stefani, M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ESMOLOL; LEVOSIMENDAN;

ACUTE HEART INFARCTION; ADULT; BLOOD CLOT LYSIS; BLOOD FLOW VELOCITY; CARDIOGENIC SHOCK; CASE REPORT; CONTINUOUS INFUSION; DIASTOLE; DRUG DOSE TITRATION; HEMODYNAMICS; HUMAN; LETTER; MALE; PRIORITY JOURNAL; ST SEGMENT ELEVATION; TACHYCARDIA; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 77249166140     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aeq013     Document Type: Letter

References (5)

1. Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. Eur Heart J 2008; 19: 2388-2442
2. Bayram M, De Luca L, Massie MB, Gheorghiade M. Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes. Am J Cardiol 2005; 96: 47-58G
3. Thackray S, Easthaugh J, Freemantle N, Cleland JG. The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure-a meta-regression analysis. Eur J Heart Fail 2002; 4: 515-529
4. Zangrillo A, Biondi-Zoccai G, Mizzi A, et al. Levosimendan reduces cardiac troponin release after cardiac surgery: a meta-analysis of randomized controlled studies. J Cardiothorac Vasc Anesth 2009; 23: 474-478
5. Russ MA, Prondzinsky R, Christoph A, et al. Hemodynamic improvement following levosimendan treatment in patients with acute myocardial infarction and cardiogenic shock. Crit Care Med 2007; 35: 2732-2739